Find News

Filter articles

Showing 131 to 140 of 3908 results

Biotech wins $16.5 million in drug royalties dispute

US18-10-2022Catherine Wycherley

Arbitration panel awarded the sum to Acorda to cover past royalties and interest | Acorda can now source the multiple sclerosis drug elsewhere.

In conversation with...Beatriz San Martin, Arnold & Porter

EU13-10-2022Sarah Speight

The scientist-turned IP specialist chats to LSIPR about why she ‘loves’ the IP sector, her views on policy and funding in science and research, and the cases she’s most proud of.

Pharma company raises pressure with hypotension drug lawsuit

US13-10-2022Muireann Bolger

Nexus raises second complaint against same parties in a month | Ready-to-use drug that can raise the blood pressure of hypotension patients at issue.

Teva breached antitrust rules over Copaxone, says EU

EU11-10-2022Sarah Speight

European Commission says pharma firm blocked generics over blockbuster MS drug| Teva “engaged in abusive conduct” to “artificially prolong the exclusivity” of Copaxone | Teva could be found to have infringed Article 102 of TFEU.

French pharma firm inks deal with tech provider

France, US11-10-2022Staff Writer

The partnership aims to progress drug discovery and development | Tech platform accelerates trials and provides higher quality trial data.

DNA test-maker demands $817m triple damages in patent win

US06-10-2022Muireann Bolger

Dispute against LabCorp claims wilful infringement | Plaintiff has also sued Illumina, Roche and Myriad in separate cases.

Generic maker hits back at Novartis stay bid

US06-10-2022Staff Writer

HEC claims the delay would buy Novartis months of “unjustified monopoly profits” | Response says the Swiss big pharma company makes $3.8m a day from multiple sclerosis drug at issue.

Patent pool inks major COVID-19 deal with Japanese company

04-10-2022Muireann Bolger

Antiviral treatment could potentially be distributed across 117 countries | MPP looks for interest from potential sublicensees

Bristows appoints new joint managing partner

UK04-10-2022Muireann Bolger

Bristows has announced that competition law expert Stephen Smith will be the new joint managing partner of the firm

SCOTUS invites govt comment on Teva clash

US04-10-2022Staff writer

Court opens door for US solicitor general to file a brief | Hard fought ‘skinny label’ case centres on a generic medicine maker excluding patent-protected indications from its labels.

Showing 131 to 140 of 3908 results